Content area

Details

Title
Nivolumab–ipilimumab — exploiting the mutation burden of NSCLCs
Author
Killock, David 1 

 Nature Reviews Clinical Oncology, 
Pages
403-403
Publication year
2018
Publication date
Jul 2018
Publisher
Nature Publishing Group
ISSN
17594774
e-ISSN
17594782
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2057073937
Copyright
Copyright Nature Publishing Group Jul 2018